ApaI VDR Polymorphism as a Risk Factor of Treatment Failure in Chronic Hepatitis C Patients
ApaI VDR Polymorphism as a Risk Factor of Treatment Failure in Chronic Hepatitis C Patients
Noora Hassan Hezam Al-Aqmer1*, Zain Aamir2, Muhammad Farooq Hanif3, Soumble Zulfiqar4, Sibgha Zulfiqar1, Mateen Izhar5 and Abdul Rauf Shakoori4*
Fig. 1.
RFLP pattern of ApaI VDR polymorphism (rs7975232) in 2% agarose gel showing homozygous wild AA genotype with a band of 744 bp (Lanes# 6, 9, 10, and 11), heterozygous Aa genotype with the bands 744, 527, and 217 bp (Lanes# 3, 4, 7, and 8), and homozygous mutant aa genotypes with the bands 527 and 217 bp (Lanes# 1, 2, and 5).
October 2022
Vol. 54, Iss. 5, Pages 2003-2500
